MENU
SLNCF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLNCF) Ownership - Who owns Silence Therapeutics?
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
Profile
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
226.72M
P/E Ratio
N/A
Total Cash
114.16M
Projected Growth
N/A
Total Debt
N/A
Revenue
27.17M
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
Fundamentals
SLNCF
Capitalization
227M
P/E Ratio
N/A
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash
114M
Total Cash/Share
0.81
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
27.2M
ROE
N/A
Book Value
94.2M
P/B Ratio
2.41
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10.3M
Current Ratio
10.06
Current Revenue Per Employee
1931.03
Dividends Per Share - Security
N/A
EBITDA
-84.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
62.05
Revenue To Assets
-39.19
Shares Held By Institutions
150
Shares Outstanding - Current
142M
Total Liabilities
71.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-39.048
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com